Earl M. Collier Jr. - 27 Feb 2025 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Role
Director
Signature
/s/ Linda Marban, Attorney-in-Fact
Issuer symbol
CAPR
Transactions as of
27 Feb 2025
Net transactions value
+$1,042
Form type
4
Filing time
28 Feb 2025, 19:30:06 UTC
Previous filing
06 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAPR Common Stock Options Exercise $1,042 +750 +1.3% $1.39 57,606 27 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAPR Stock Option (Right to Buy) Options Exercise $0 -750 -100% $0.000000 0 27 Feb 2025 Common Stock 750 $1.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 3, 2015 and was previously reported as covering 7,500 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
F2 The shares were fully vested and exercisable as of March 3, 2015, the date of grant.